 |
PDBsum entry 4ff8
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Transferase/transferase inhibitor
|
PDB id
|
|
|
|
4ff8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Transferase/transferase inhibitor
|
 |
|
Title:
|
 |
Inhibitor bound structure of the kinase domain of the murine receptor tyrosine kinase tyro3 (sky)
|
|
Structure:
|
 |
Tyrosine-protein kinase receptor tyro3. Chain: a. Synonym: etk2/tyro3, tk19-2, tyrosine-protein kinase dtk, tyrosine- protein kinase rse. Engineered: yes. Mutation: yes
|
|
Source:
|
 |
Mus musculus. Mouse. Organism_taxid: 10090. Gene: tyro3, dtk, rse. Expressed in: spodoptera frugiperda. Expression_system_taxid: 7108
|
|
Resolution:
|
 |
|
2.40Å
|
R-factor:
|
0.279
|
R-free:
|
0.324
|
|
|
Authors:
|
 |
J.F.Ohren,N.A.Powell,J.Kohrt,L.A.Perrin
|
|
Key ref:
|
 |
N.A.Powell
et al.
(2013).
Highly selective 2,4-diaminopyrimidine-5-carboxamide inhibitors of Sky kinase.
Bioorg Med Chem Lett,
23,
1046-1050.
PubMed id:
|
 |
|
Date:
|
 |
|
31-May-12
|
Release date:
|
13-Mar-13
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P55144
(TYRO3_MOUSE) -
Tyrosine-protein kinase receptor TYRO3 from Mus musculus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
880 a.a.
169 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.2.7.10.1
- receptor protein-tyrosine kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
L-tyrosyl-[protein] + ATP = O-phospho-L-tyrosyl-[protein] + ADP + H+
|
 |
 |
 |
 |
 |
L-tyrosyl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-tyrosyl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
|
Bioorg Med Chem Lett
23:1046-1050
(2013)
|
|
PubMed id:
|
|
|
|
|
| |
|
Highly selective 2,4-diaminopyrimidine-5-carboxamide inhibitors of Sky kinase.
|
|
N.A.Powell,
J.K.Hoffman,
F.L.Ciske,
M.D.Kaufman,
J.T.Kohrt,
J.Quin,
D.J.Sheehan,
A.Delaney,
S.M.Baxi,
C.Catana,
P.McConnell,
J.Ohren,
L.A.Perrin,
J.J.Edmunds.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
We report the SAR around a series of 2,4-diaminopyrimidine-5-carboxamide
inhibitors of Sky kinase. 2-Aminophenethyl analogs demonstrate excellent potency
but moderate kinase selectivity, while 2-aminobenzyl analogs that fill the
Ala571 subpocket exhibit good inhibition activity and excellent kinase
selectivity.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |